Muscle and Cerebral Oxygenation Under EVAR of AAA: GA vs LA
Launched by RIGSHOSPITALET, DENMARK · Sep 18, 2015
Trial Information
Current as of April 27, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Scheduled procedure
- Exclusion Criteria:
- • allergies for used local anaesthesia
- • have had vascular surgery before in the femoral area
- • the need for thromboendarterectomy in common femoral artery
- • the need for aortouniiliac stent-graft with cross-over bypass
- • severe back pain
- • expected time of surgery more than 1.5 hour
- • cognitive dysfunction making cooperation during procedure impossible
- • Femoral amputee
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials